| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10342813 | HQ SPCLT PHARMA | Calcium gluconate solutions in flexible containers |
Jul, 2037
(13 years from now) | |
| US10130646 | HQ SPCLT PHARMA | Calcium gluconate solutions in flexible containers |
Jul, 2037
(13 years from now) | |
Calcium Gluconate In Sodium Chloride is owned by Hq Spclt Pharma.
Calcium Gluconate In Sodium Chloride contains Calcium Gluconate.
Calcium Gluconate In Sodium Chloride has a total of 2 drug patents out of which 0 drug patents have expired.
Calcium Gluconate In Sodium Chloride was authorised for market use on 29 October, 2018.
Calcium Gluconate In Sodium Chloride is available in solution;intravenous dosage forms.
The generics of Calcium Gluconate In Sodium Chloride are possible to be released after 25 July, 2037.
Drugs and Companies using CALCIUM GLUCONATE ingredient
Market Authorisation Date: 29 October, 2018
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
CALCIUM GLUCONATE IN SODIUM CHLORIDE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic